Trials / Completed
CompletedNCT01359423
Comparison of Primary Long Full Coverage Stenting vs Primary Short Spot Stenting for Long Femoropopliteal Artery Disease.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 89 (actual)
- Sponsor
- Yonsei University · Academic / Other
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis: Primary long full coverage stenting is superior to primary short spot stenting in the treatment of long (≥80 mm) femoropopliteal artery lesions. Study design : * Prospective, randomized, multi-center study * A total of 220 subjects with symptomatic peripheral artery disease of lower limbs who meet all inclusion and exclusion criteria will be included. * Patients will be randomized in a two by two factorial manner according to the strategy of stenting (long versus short stenting) and the additional use of cilostazol. Each randomization of the enrolled subjects will be done 1:1. * Patients will be followed clinically for 1 year after the procedure. * Angiographic or CT follow-up will be performed at 1 year.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Percutaneous transluminal angioplasty of femoropopliteal artery lesions with primary long | Patients will be randomized in a two-by-two factorial manner according to the use of IVUS guidance (IVUS guidance vs. no IVUS guidance) for the PCI and the duration of dual anti-platelet therapy (100 mg/day aspirin and 75mg/day clopidogrel for 6 months vs. 12 months) after PCI. Each randomization of the enrolled subjects will be done 1:1. |
| DRUG | short stenting for the primary outcome and use of cilostazol for 12 months for secondary outcome. | Patients will be randomized in a two-by-two factorial manner according to the use of IVUS guidance (IVUS guidance vs. no IVUS guidance) for the PCI and the duration of dual anti-platelet therapy (100 mg/day aspirin and 75mg/day clopidogrel for 6 months vs. 12 months) after PCI. Each randomization of the enrolled subjects will be done 1:1. |
Timeline
- Start date
- 2011-09-26
- Primary completion
- 2017-08-10
- Completion
- 2017-08-10
- First posted
- 2011-05-24
- Last updated
- 2017-11-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01359423. Inclusion in this directory is not an endorsement.